Clinical Trials Directory

Trials / Unknown

UnknownNCT03146182

Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Gertrud Baunbaek Egelund · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the efficacy of C-reactive protein and procalcitonin based guidelines versus standard of care to reduce duration of antibiotic exposure in patients hospitalized with community acquired pneumonia.

Detailed description

BIO-CAP is a prospective randomized intervention study which aims to evaluate the efficacy of C-reactive protein (CRP) based guidelines and procalcitonin (PCT) based guidelines to reduce duration of antibiotic exposure in adult patients hospitalized with community-acquired pneumonia (CAP) compared to standard-of-care. Hypothesis: the duration of antibiotic exposure can be reduced when a biomarker algorithm - in addition to standard of care - is used to stop antibiotic treatment. 1\) CRP based guidelines can reduce duration of antibiotic exposure equally to procalcitonin based guidelines and 2) Either of these two biomarker algorithms ( CRP or PCT) are superior compared to standard of care. Sample size. Preconditions: significance level (α) 5 % and power (β) 80 %. Test: unpaired T-test. Mean treatment time 11 days (SD 5) in this population. Relevant detection limit defined at 2 days. The bonferroni correction has been used to correct for the fact that 2 primary analysis will be performed, why α = 0.005/2 = 0.025. Estimated 100 patient in each arm, thus n = 300. Site monitoring and auditing. The study is monitored by the unit for Good Clinical Practice, Bispebjerg Hospital, Denmark.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCRP-algorithma strategy based on CRP guided antibiotic stewardship
BEHAVIORALPCT-algorithma strategy based on PCT guided antibiotic stewardship

Timeline

Start date
2017-03-15
Primary completion
2018-12-01
Completion
2019-02-01
First posted
2017-05-09
Last updated
2017-05-10

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03146182. Inclusion in this directory is not an endorsement.